Dimension Therapeutics
Dimension Therapeutics was a Cambridge, Massachusetts biotechnology company developing liver-directed gene therapies for rare diseases. Incorporated in 2013, it was acquired by Ultragenyx in November 2017 and had merged into Ultragenyx, ceasing its separate corporate existence, by March 31, 2019.
Key facts
| Business Model | Commerce |
|---|---|
| Legal Name | Dimension Therapeutics, Inc. |
| Company Operating Status | Closed |
| Full Address | 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 |
| Wellfound ID | dimension-therapeutics |
| Wikidata ID | Q30268909 |